webcast resource

Message from HRH Princess Astrid of Belgium

A 50-year history of clinical cancer research

March 15, 2012 | Length: 4:28 min


Congress:EORTC 50th Anniversary Conference
Presenter:HRH Princess Astrid of Belgium

As Honorary President of the EORTC Charitable Trust, I want to express my personal thanks to all of you for your commitment to EORTC.
EORTC is a unique clinical and translational research organization in Europe. EORTC was founded in 1962 under Belgian law by a group of oncologists including Professor Henri Tagnon.
The mission of EORTC is to promote, to coordinate, to stimulate and to publish clinical research in cancer by groups of researchers in multidisciplinary studies.
More than 6000 patients (involving more than 600 Belgian patients) participated each year in EORTC Clinical Trials.
The Headquarters of EORTC is located in Brussels and comprises 180 staff members.
The ultimate goal of EORTC is to improve the standard of cancer treatment by way of testing more effective therapeutic strategies based on drugs.
Tremendous progress has been accomplished in the last 50 years. Current cancer research under the lead of EORTC will increase chance of survival and quality of life for patients with cancer.